ConductScience.org, home

Paper40046366

Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa.

Miyaishi M and 4 others. Cureus, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa. Papers, record 40046366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40046366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oral Cornstarch and Glycyrrhizin Improve Severe Liver Injury Caused by Glycogen Storage Disease Type IXa.
PubMed
Journal
Cureus
PubMed
Year
2025
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-03-07
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miyaishi MMasanori
2Fukushima KKenji
3Kuranobu NNaomi
4Murakami JJun
5Namba NNoriyuki

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130553196Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25.Biomed Pharmacother2019https://conductscience.org/library/papers/30553196PubMed
217689125Glycogen storage disease type IX: High variability in clinical phenotype.Mol Genet Metab2007https://conductscience.org/library/papers/17689125PubMed
326965985Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis.Drug Metab Dispos2016https://conductscience.org/library/papers/26965985PubMed
432505569Liver histology in children with glycogen storage disorders type VI and IX.Dig Liver Dis2021https://conductscience.org/library/papers/32505569PubMed
532633407Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury.Eur Rev Med Pharmacol Sci2020https://conductscience.org/library/papers/32633407PubMed
633342284Post-treatment with glycyrrhizin can attenuate hepatic mitochondrial damage induced by acetaminophen in mice.Exp Biol Med (Maywood)2021https://conductscience.org/library/papers/33342284PubMed
714767974Apoptosis: the nexus of liver injury and fibrosis.Hepatology2004https://conductscience.org/library/papers/14767974PubMed
823578772Aggressive therapy improves cirrhosis in glycogen storage disease type IX.Mol Genet Metab2013https://conductscience.org/library/papers/23578772PubMed
921646031Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies.Mol Genet Metab2011https://conductscience.org/library/papers/21646031PubMed
1028317891Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa).Sci Rep2017https://conductscience.org/library/papers/28317891PubMed
1117514432A novel starch for the treatment of glycogen storage diseases.J Inherit Metab Dis2007https://conductscience.org/library/papers/17514432PubMed
1231665208Dietary Management of the Glycogen Storage Diseases: Evolution of Treatment and Ongoing Controversies.Adv Nutr2020https://conductscience.org/library/papers/31665208PubMed
1333317799Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.Mol Genet Metab2020https://conductscience.org/library/papers/33317799PubMed
1436817397Interleukin 25 and its biological features and function in intestinal diseases.Cent Eur J Immunol2022https://conductscience.org/library/papers/36817397PubMed
1530659246Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genet Med2019https://conductscience.org/library/papers/30659246PubMed

Download CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PHKA25256PubTator's text mininghttps://conductscience.org/library/genes/5256

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40046366

GET https://conductscience.org/api/papers/v1/40046366/authors